Blog Archives

PRESS RELEASE: $1.5M NIH Funding To Expand Parkinson’s Telemedicine To Mobile Apps

VIEW PRESS RELEASE 15 APR 2014: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they will be using a $1.5M award from NIH to expand their Parkinson’s monitoring technology to mobile applications. Repositioning GLNT’s Kinesia™ product line with mobile apps strategically aligns with growing trends in domestic and

Read more ›


PRESS RELEASE: Great Lakes NeuroTechnologies Continues Intellectual Property Growth As New Patent Claims Focus On Parkinson’s Device Accuracy And Sensitivity

VIEW PRESS RELEASE 05 MAR 2014: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received a new allowance of claims from the U.S. Patent Office, the company’s fourth in the past eight months focused on technology for Parkinson’s disease diagnostics and treatment.


Continuous In-Home Monitoring Of Essential Tremor

C. Pulliam, S. Eichenseer, C. Goetz, O. Waln, C. Hunter, J. Jankovic, D. Vaillancourt, J. Giuffrida, And D. Heldman Parkinsonism Relat Disord. 2014 Jan;20(1):37-40.


Tradeshow Event: Partnership in Clinical Trials

The Mirage Hotel Las Vegas, NV March 31 – April 2 2014 Conference home page We will be exhibiting at booth #1305 . We will be demonstrating out Kinesia HomeView and ProView systems. From the 2013 event: This year’s event brings together upwards of 1300 clinical decision makers for four

Read more ›


PRESS RELEASE: GLNT Awarded Patent For Sensor Based Continuous Parkinson’s Assessment During Daily Activities

VIEW PRESS RELEASE [PDF] 03 DEC 2013: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received allowance of claims from the U.S. Patent Office for an application covering their system and method of continuous monitoring of motor symptoms associated with movement disorders such as Parkinson’s disease. The

Read more ›


PRESS RELEASE: GLNT Expanding Telemedicine Technology for Parkinson’s Disease

VIEW PRESS RELEASE [PDF] 05 Sept 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they are launching commercialization and clinical studies to expand their telemedicine technology, Kinesia HomeView™ [ http://glneurotech.com/kinesia/homeview/ ], for individuals with Parkinson’s disease by adding real-time video conferencing. The research and development are being

Read more ›


Continuous home monitoring of essential tremor using motion sensors

C. Pulliam, S. Eichenseer, C. Goetz, O. Waln, C. Hunter, J. Jankovic, D. Vaillancourt, J. Giuffrida, and D. Heldman 65th Annual Meeting of the American Academy of Neurology, San Diego, CA, 2013


Home-based Motion Sensor Monitoring for Parkinson’s Disease Clinical Trials

View Poster D. Heldman, A. Espay, P. LeWitt, J. Giuffrida 3rd World Parkinson Congress. Montreal, Canada, 2013


PRESS RELEASE: Great Lakes NeuroTechnologies’ Kinesia Technology Receives TGA Approval for Parkinson’s Assessment in Australia

VIEW PRESS RELEASE [PDF] 9 JAN 2013: Valley View, OH – Great Lakes NeuroTechnologies announced today that they received TGA approval to market Kinesia technology in Australia. The Kinesia™ product line [ http://glneurotech.com/kinesia/ ] includes patient-worn motion sensors and a tablet computer to quantitatively assess tremor, bradykinesia, and dyskinesia associated

Read more ›


PRESS RELEASE: GLNT Stimulates Job Growth in Northeast Ohio Biotechnology Market

VIEW PRESS RELEASE [PDF] 18 Oct 2012: Valley View, OH – In 2012, Great Lakes NeuroTechnologies has grown its workforce by 50%, bringing sustainable, high-tech jobs to Northeast Ohio.  Since 2006, the team at the biotech company has focused on developing innovative medical devices, specifically in the area of movement

Read more ›